2023 Impact Factor
2023 Impact Factor
Process of Study Identification. Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) flow diagram illustrating the process of study dentification for our scoping review. Includes the identification, screening, and inclusion stages.
Contraction reserve (CR) between patients with ineffective esophageal motility (IEM) applied by Chicago classification version 4.0 (CC v4.0) to 10 upright swallows and assessed with 1 and 3 upright multiple rapid swallows (MRS) sequences. Numbers above the bars represent percentages. *Significance in pairwise comparison to patients with 1 MRS sequence performed. DCI, distal contraction integral.
Representative awake (A) and sedated (B) functional lumen imaging probe (FLIP) Panometry. Two FLIP Panometry studies from the same subject ([A] awake, [B] sedated with midazolam and fentanyl) with output including FLIP fill volume (top), diameter topography (center), and pressure (bottom) are displayed. The perception score by FLIP fill volume is also displayed for the awake study (A).
Spearman correlation coefficients between baseline impedance measured during high-resolution impedance manometry (HRIM-BI) and mean nocturnal baseline impedance (MNBI). CTRS, concomitant typical reflux syndrome; ILPRS, isolated laryngopharyngeal reflux symptoms; UES, upper esophageal sphincter; LES, lower esophageal sphincter.
Endoscopic findings and high-resolution impedance manometry (HRIM) in a representative case before and 3 months after antireflux mucosal ablation (ARMA). (A) Wide cardia opening (gastroesophageal flap valve grade III) before ARMA. (B) Tightened cardia (gastroesophageal flap valve grade I) after ARMA. (C) Absent contractility (100% failed contraction) on HRIM before ARMA. (D) Improved esophageal motility (10% intact, 40% weak, and 50% failed contraction) after ARMA.
Non-inferiority in erosive esophagitis (EE) healing rate at weeks 2 and 4 in the full analysis set and per-protocol set. The light gray vertical line represents the non-inferiority margin (–15.00%). The dark gray horizontal line is the confidence interval (CI) of study results. The diamond shape in the middle means risk difference. In all analyses, CIs (horizontal line) did not include the non-inferiority margin (vertical line). Thus, non-inferiorities were proven.
J Neurogastroenterol Motil 2025; 31(1): 1~128 
Total PDF
.jpg)
